Aromatase activity in a rat Leydig cell tumor

Area of Science:

• Endocrinology
• Oncology
• Biochemistry

Background:

• Male Wistar-Furth rats with LTW(m) Leydig cell tumors show elevated serum estradiol (E2).
• Understanding the source of elevated E2 is crucial for tumor biology and potential therapeutic targets.

Purpose of the Study:

• To investigate the aromatase activity of LTW(m) Leydig cell tumors.
• To determine the responsiveness of tumor aromatase to various stimulatory and inhibitory agents.

Main Methods:

• Tumor minces and cell cultures were used to measure testosterone (T) aromatization to E2.
• Radioisotope ([3H]T) and water ([3H]H2O) conversion assays quantified aromatase activity.
• Enzyme kinetics (Vmax, Km) were determined, and responses to hCG, cAMP, phorbol esters, beta-endorphin, naloxone, and 4-hydroxy-4-androstene-3,17-dione were assessed.

Main Results:

• LTW(m) Leydig cell tumors demonstrated significantly higher aromatase activity compared to normal rat testicular tissue.
• Aromatase activity was primarily localized to tumor microsomes, with kinetic parameters (Vmax, Km) established.
• Tumor aromatase was unresponsive to hCG, (Bu)2cAMP, and phorbol esters, unlike normal testicular cells.
• 4-hydroxy-4-androstene-3,17-dione effectively inhibited tumor aromatase activity.

Conclusions:

• The LTW(m) rat Leydig cell tumor possesses an autonomous and highly active aromatase system.
• This tumor-associated aromatase is refractory to adenylate cyclase-mediated stimulation.
• The findings identify 4-hydroxy-4-androstene-3,17-dione as a potential inhibitor of this tumor's estrogen production.